Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
复制标题
DOI：
10.1016/0169-5002(94)90879-6
复制
发表时间：
1993-04
期刊：
影响因子：
11.2
通讯作者：
E. Rowinsky;D. Noe;D. Ettinger;M. Christian;B. Lubejko;E. Fishman;S. Sartorius;M. Boyd;R. Donehow
中科院分区：
文献类型：
--
作者：
E. Rowinsky;D. Noe;D. Ettinger;M. Christian;B. Lubejko;E. Fishman;S. Sartorius;M. Boyd;R. Donehow
